|
|
| | Olorinab Basic information |
| Product Name: | Olorinab | | Synonyms: | Olorinab;1H-Cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide, 4,4a,5,5a-tetrahydro-N-[(1S)-1-(hydroxymethyl)-2,2-dimethylpropyl]-1-(4-oxido-2-pyrazinyl)-, (4aS,5aS)-;APD 371 - Bio-X;(2S,4S)-N-[(1S)-1-(hydroxymethyl)-2,2-dimethyl-propyl]-9-(4-oxidopyrazin-4-ium-2-yl)-8,9-diazatricyclo[4.3.0.02?]nona-1(6),7-diene-7-carboxamide;3-[(4aS,5aS)-3-[[(S)-1-Hydroxy-3,3-dimethyl-2-butyl]carbamoyl]-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazol-1-yl]pyrazine 1-Oxide | | CAS: | 1268881-20-4 | | MF: | C18H23N5O3 | | MW: | 357.41 | | EINECS: | | | Product Categories: | | | Mol File: | 1268881-20-4.mol |  |
| | Olorinab Chemical Properties |
| Boiling point | 636.6±55.0 °C(Predicted) | | density | 1.49±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Chloroform (Slightly), Methanol (Slightly) | | pka | 13.39±0.20(Predicted) | | form | Solid | | color | White to Off-White |
| | Olorinab Usage And Synthesis |
| Uses | APD371 is potent and selective Cannabinoid Receptor Type 2 (CB2) Agonist. It is orally available and has analgesic effects used as possible treatment to chronic pain. |
| | Olorinab Preparation Products And Raw materials |
| Raw materials | Olorinab 1268881-17-9-->1H-Cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxylic acid, 4,4a,5,5a-tetrahydro-1-(2-pyrazinyl)-, ethyl ester, (4aS,5aS)--->1H-Cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxylic acid, 4,4a,5,5a-tetrahydro-1-(2-pyrazinyl)-, (4aS,5aS)--->(2S,4S)-9-(4-oxidopyrazin-4-ium-2-yl)-8,9-diazatricyclo[4.3.0.02]nona-1(6),7-diene-7-carboxylic acid-->(S)-(-)-1,2-Epoxy-5-hexene, GC 99%-->Bicyclo[3.1.0]hexan-2-one, (1S,5R)--->(S)-TERT-LEUCINOL |
|